WO2024094637A1 - Process for the preparation of cyclic ketones - Google Patents

Process for the preparation of cyclic ketones Download PDF

Info

Publication number
WO2024094637A1
WO2024094637A1 PCT/EP2023/080263 EP2023080263W WO2024094637A1 WO 2024094637 A1 WO2024094637 A1 WO 2024094637A1 EP 2023080263 W EP2023080263 W EP 2023080263W WO 2024094637 A1 WO2024094637 A1 WO 2024094637A1
Authority
WO
WIPO (PCT)
Prior art keywords
carbamate
optionally substituted
chloride
bromide
formula
Prior art date
Application number
PCT/EP2023/080263
Other languages
French (fr)
Inventor
Ulrich MAYERHOEFFER
Arne Jan STEPEN
Emilia PAUNESCU
Maria Luisa SEBASTIAN IBARZ
Original Assignee
Arxada Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Arxada Ag filed Critical Arxada Ag
Publication of WO2024094637A1 publication Critical patent/WO2024094637A1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C67/00—Preparation of carboxylic acid esters
    • C07C67/08—Preparation of carboxylic acid esters by reacting carboxylic acids or symmetrical anhydrides with the hydroxy or O-metal group of organic compounds
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C269/00—Preparation of derivatives of carbamic acid, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
    • C07C269/06—Preparation of derivatives of carbamic acid, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups by reactions not involving the formation of carbamate groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C273/00—Preparation of urea or its derivatives, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
    • C07C273/18—Preparation of urea or its derivatives, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups of substituted ureas
    • C07C273/1854—Preparation of urea or its derivatives, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups of substituted ureas by reactions not involving the formation of the N-C(O)-N- moiety
    • C07C273/1863—Preparation of urea or its derivatives, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups of substituted ureas by reactions not involving the formation of the N-C(O)-N- moiety from urea
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C303/00—Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides
    • C07C303/26—Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides of esters of sulfonic acids
    • C07C303/28—Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides of esters of sulfonic acids by reaction of hydroxy compounds with sulfonic acids or derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C67/00—Preparation of carboxylic acid esters
    • C07C67/14—Preparation of carboxylic acid esters from carboxylic acid halides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C68/00—Preparation of esters of carbonic or haloformic acids
    • C07C68/02—Preparation of esters of carbonic or haloformic acids from phosgene or haloformates
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C68/00—Preparation of esters of carbonic or haloformic acids
    • C07C68/06—Preparation of esters of carbonic or haloformic acids from organic carbonates
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/04—Systems containing only non-condensed rings with a four-membered ring

Definitions

  • the present invention relates to a process for the preparation of cyclobutenone derivatives.
  • Functionalized cyclobutenone derivatives are valuable intermediates for the production of various compounds such as pharmaceutical and agrochemical agents.
  • 3-acetoxy-2-cyclobuten-1-one also known as triketene
  • Triketene is a side product in the diketene production and is typically obtained by distillation from the distillation residue obtained in the diketene production.
  • the distillation residue from the diketene production which is also referred to as triketene resin, typically comprises 10% diketene, 30% triketene and 60% undefined compounds.
  • the production of triketene by distillation of triketene resin is disclosed in CH 596 132.
  • this method suffers inter alia from the drawback that only triketene and no other functionalized cyclobutenone derivatives can be obtained.
  • An object of the present invention is to provide an excellent process for the synthesis of cyclobutenone derivatives.
  • a further object of the present invention is to provide a process which provides various cyclobutenone derivatives. Summary of the invention
  • the present invention provides a process for the preparation of a compound of formula (1) wherein
  • Y is O or NH
  • R is -C(O)-R 1 or -S(0) 2 -R 1 , and
  • R 1 is selected from optionally substituted linear or branched C1-12 alkyl, optionally substituted C3-8 cycloalkyl, optionally substituted C3-8 cycloalkenyl, optionally substituted aryl, -NR 5 R 6 , -OR 7 , and halogen, wherein R 5 , R 6 , and R 7 are each independently selected from H, optionally substituted linear or branched C1-12 alkyl, optionally substituted C3-8 cycloalkyl, optionally substituted C3-8 cycloalkenyl, and optionally substituted aryl; the process comprising reacting a compound of formula (2)
  • a + wherein A+ is an ammonium group of formula (3) wherein R 2 , R 3 , and R 4 are each independently selected from H, optionally substituted linear or branched C1-12 alkyl, and optionally substituted C3-8 cycloalkyl, with a compound of formula (4), (5), (6), or (7) wherein X is selected from F, Cl, Br, or I, wherein the process excludes reacting 3-hydroxy-2-cyclobuten-1-one dicyclohexylammonium salt with trimethylacetyl chloride.
  • linear or branched C1-12 alkyl refers to a straight- chained or branched saturated hydrocarbon group having 1 to 12 carbon atoms, such as 1 , 2, 3, 4, 5, 6, 7, 8, 9, 10, 11 or 12 carbon atoms.
  • linear or branched C1-6 alkyl refers to a straight-chained or branched saturated hydrocarbon group having 1 to 6 carbon atoms (i.e.
  • C3-8 cycloalkyl refers to monocyclic saturated hydrocarbon groups having 3 to 8 carbon ring members (i.e. 1 , 2, 3, 4, 5, 6, 7, or 8 carbon atoms) including cyclopropyl, cyclobutyl, cyclopentyl, cyclohexyl, cycloheptyl, and cyclooctyl.
  • C3-6 cycloalkyl refers to monocyclic saturated hydrocarbon radicals having 3 to 6 carbon ring members (i.e. 1 , 2, 3, 4, 5, or 6 carbon atoms) including cyclopropyl, cyclobutyl, cyclopentyl, and cyclo hexyl.
  • C3-8 cycloalkenyl refers to monocyclic alkene hydrocarbon groups having 3 to 8 carbon ring members (i.e. 1 , 2, 3, 4, 5, 6, 7, or 8 carbon atoms) that include at least one carbon-carbon double bond in the ring of carbon atoms.
  • C3-8 cycloalkenyl include cyclopropenyl, cyclobutenyl, cyclopentenyl, cyclohexenyl, cycloheptenyl, 1 ,3- cyclohexadienyl, 1 ,4-cyclohexadienyl, 1 ,5-cyclooctadienyl, cis-cyclooctenyl, and trans-cyclooctenyl.
  • aryl refers to refers to both single-ring aromatic hydrocarbyl groups and polycyclic aromatic ring systems.
  • the polycyclic rings may have two or more rings in which two carbons are common to two adjoining rings (the rings are "fused") wherein at least one of the rings is an aromatic hydrocarbyl group, e.g., the other rings can be cycloalkyls, cycloalkenyls, aryl, heterocycles, and/or heteroaryls.
  • Preferred aryl groups are those containing six to twelve carbon atoms. Especially preferred is an aryl group having six carbons, ten carbons or twelve carbons.
  • Suitable aryl groups include phenyl, biphenyl, triphenyl, triphenylene, tetraphenylene, naphthalene, anthracene, phenalene, phenanthrene, fluorene, pyrene, chrysene, perylene, and azulene, preferably phenyl, biphenyl, triphenyl, triphenylene, fluorene, and naphthalene.
  • linear or branched C1-12 alkyl, C3-8 cycloalkyl, C3-8 cycloalkenyl and aryl may optionally be further substituted.
  • halogen refers to fluorine, chlorine, bromine and iodine.
  • tolyl includes o-tolyl, m-tolyl, and p-tolyl.
  • subject of the present invention is a process for the preparation of a compound of formula (1) wherein
  • Y is O or NH
  • R is -C(O)-R 1 or -S(0) 2 -R 1 , and
  • R 1 is selected from optionally substituted linear or branched C1-12 alkyl, optionally substituted C3-8 cycloalkyl, optionally substituted C3-8 cycloalkenyl, optionally substituted aryl, -NR 5 R 6 , -OR 7 , and halogen, wherein R 5 , R 6 , and R 7 are each independently selected from H, optionally substituted linear or branched C1-12 alkyl, optionally substituted C3-8 cycloalkyl, optionally substituted C3-8 cycloalkenyl, and optionally substituted aryl; the process comprising reacting a compound of formula (2) wherein A+ is an ammonium group of formula (3) wherein R 2 , R 3 , and R 4 are each independently selected from H, optionally substituted linear or branched C1-12 alkyl, and optionally substituted C3-8 cycloalkyl, with a compound of formula (4), (5), (6), or (7) wherein X is selected from F,
  • the inventive process provides an excellent route for the preparation of compounds of formula (1). Particularly, it has been surprisingly found that the inventive process is atom efficient and produces low amounts of waste. Furthermore, with the inventive process for the preparation of compounds of formula (1) various cyclobutenone derivatives are accessible. Reacting a compound of formula (2) also has the advantage that different reactions are possible and cyclobutenone derivatives of formula (1) are accessible. Moreover, the inventors surprisingly found that with the inventive process for the preparation of compounds of formula (1), various cyclobutenone derivatives are obtainable without the use of a catalyst.
  • R 1 is selected from optionally substituted linear or branched Ci-e alkyl, optionally substituted C3-8 cycloalkyl, optionally substituted C3-8 cycloalkenyl, phenyl, benzyl, tolyl, - NR 5 R 6 , -OR 7 , and halogen.
  • R 1 is selected from optionally substituted linear or branched C1-6 alkyl, optionally substituted C3-6 cycloalkyl, phenyl benzyl, tolyl, -NR 5 R 6 , -OR 7 , and halogen.
  • R 1 is selected from methyl, ethyl, propyl, 1 -methylethyl, butyl, 1 -methylpropyl, 2-methylpropyl, tert-butyl, pentyl, hexyl, cyclopropyl, cyclobutyl, cyclopentyl, cyclohexyl, phenyl, tolyl, and benzyl.
  • R 1 is methyl, tert-butyl, phenyl, tolyl, or benzyl.
  • R is -C(O)-R 1 and R 1 is selected from -NR 5 R 6 , -OR 7 , and halogen
  • R 5 is H and R 6 and R 7 are optionally substituted C3-8 cycloalkenyl, More preferably, R 5 is H and R 6 and R 7 are 3-oxo-cyclobuten-1-yl.
  • halogen is Cl or Br, more preferably Cl.
  • R is -C(O)-R 1 and R 1 is -OR 7 . In one embodiment, R is -C(O)-R 1 and R 1 is - OR 7 and R 7 is 3-oxo-cyclobuten-1-yl or methyl.
  • R is -C(O)-R 1 and R 1 is-NR 5 R 6 . In one embodiment, R is -C(O)-R 1 and R 1 is- NR 5 R 6 and R 5 is H and R 6 is 3-oxo-cyclobuten-1-yl. In one embodiment, in the ammonium group of formula (3), R 2 is H, and R 3 and R 4 are each independently selected from optionally substituted linear or branched C1-12 alkyl, and optionally substituted C3-8 cycloalkyl.
  • R 2 is H
  • R 3 and R 4 are cyclohexyl.
  • the compound of formula (2) is 3-hydroxy-2-cyclobuten-1-one dicyclohexylammonium salt, depicted by the following formula:
  • the compound of formula (4) is selected from the group consisting of acetyl chloride, acetyl bromide, propionyl chloride, propionyl bromide, butyryl chloride, butyryl bromide, isobutyryl chloride, isobutyryl bromide, trimethylacetyl chloride, trimethylacetyl bromide, tertbutylacetyl chloride, tert-butylacetyl bromide, benzoyl chloride, benzoyl bromide, phosgene, methyl chloroform ate, ethyl chloroformate, propyl chloroformate, 1 -methylethyl chloroform ate, butyl chloroform ate, 1 -methylpropyl chloroform ate, 2-methylpropyl chloroform ate, 1 ,1 -dimethylethyl chloroform ate, pentyl chloroform ate, 1 -methylbutyl
  • the compound of formula (4) is selected from the group consisting of acetyl chloride, acetyl bromide, trimethylacetyl chloride, trimethylacetyl bromide, benzoyl chloride, benzoyl bromide, phosgene, 3-oxo-cyclobuten-1-yl chloroform ate, 3-oxo-cyclobuten-1-yl bromoformate, cyclohexenyl chloroform ate, cyclohexenyl bromoformate, phenyl chloroformate, phenyl bromoformate, benzyl chloroform ate, and benzyl bromoformate.
  • the compound of formula (4) is selected from the group consisting of acetyl chloride, propionyl chloride, butyryl chloride, isobutyryl chloride, trimethylacetyl chloride, tertbutylacetyl chloride, benzoyl chloride, phosgene, 3-oxo-cyclobuten-1-yl chloroform ate, cyclohexenyl chloroform ate, phenyl chloroform ate, and benzyl chloroformate.
  • the compound of formula (4) is selected from the group consisting of acetyl chloride, trimethylacetyl chloride, benzoyl chloride, phosgene, and 3-oxo-cyclobuten-1-yl chloroform ate.
  • the compound of formula (4) is selected from the group consisting of acetyl bromide, propionyl bromide, butyryl bromide, isobutyryl bromide, trimethylacetyl bromide, tertbutylacetyl bromide, benzoyl bromide, phosgene, 3-oxo-cyclobuten-1-yl bromoformate, cyclohexenyl bromoformate, phenyl bromoformate, and benzyl bromoformate.
  • the compound of formula (4) is selected from the group consisting of acetyl bromide, trimethylacetyl bromide, benzoyl bromide, phosgene, and 3-oxo-cyclobuten-1-yl bromoformate.
  • the inventive process does not encompass reacting 3-hydroxy-2-cyclobuten-1-one dicyclohexylammonium salt as the compound of formula (2) with trimethylacetyl chloride (compound of formula (4)) to obtain 3-oxocyclobut-1-en-1-yl pivalate (compound of formula (1)).
  • the compound of formula (5) is selected from the group consisting of triphosgene, acetic anhydride, propanoic anhydride, butyric anhydride, isobutyric anhydride, trimethylacetic anhydride, benzoic anhydride and cyclopropanecarboxylic acid anhydride.
  • the compound of formula (5) is acetic anhydride.
  • the compound of formula (6) is selected from the group consisting of methanesulfonyl chloride, methanesulfonyl bromide, ethanesulfonyl chloride, ethanesulfonyl bromide, 1 -propanesulfonyl chloride, 1 -propanesulfonyl bromide, 2-propanesulfonyl chloride, 3- propanesulfonyl bromide, butanesulfonyl chloride, butanesulfonyl bromide, butane-2-sulfonyl chloride, butane-2-sulfonyl bromide, 2-methyl-2-propanesulfonyl chloride, 2-methyl-2- propanesulfonyl bromide, benzenesulfonyl chloride, benzenesulfonyl bromide, toluenesulfonyl chloride, and toluenesulf
  • toluenesulfonyl chloride is p-toluenesulfonyl chloride.
  • toluenesulfonyl bromide is p-toluenesulfonyl bromide.
  • the compound of formula (6) is selected from the group consisting of methanesulfonyl chloride, ethanesulfonyl chloride, 1 -propanesulfonyl chloride, 2-propanesulfonyl chloride, butanesulfonyl chloride, butane-2-sulfonyl chloride, 2-methyl-2-propanesulfonyl chloride, benzenesulfonyl chloride, and toluenesulfonyl chloride.
  • the compound of formula (6) is selected from the group consisting of methanesulfonyl bromide, ethanesulfonyl bromide, 1 -propanesulfonyl bromide, 2-propanesulfonyl bromide, butanesulfonyl bromide, butane-2-sulfonyl bromide, 2-methyl-2-propanesulfonyl bromide, benzenesulfonyl bromide, and toluenesulfonyl bromide.
  • the compound of formula (7) is selected from the group consisting of urea, methyl carbamate, ethyl carbamate, propyl carbamate, 1 -methylethyl carbamate, butyl carbamate, 1 -methylpropyl carbamate, 2-methylpropyl carbamate, 1 ,1 -dimethylethyl carbamate, pentyl carbamate, 1 -methylbutyl carbamate, 2-methylbutyl carbamate, 3-methylbutyl carbamate, 2,2- dimethylpropyl carbamate, 1 -ethylpropyl carbamate, 1 ,1 -dimethylpropyl carbamate, 1 ,2- dimethylpropyl carbamate, hexyl carbamate, 1 -methylpentyl carbamate, 2-methylpentyl carbamate, 3-methylpentyl carbamate, 4-methylpentyl carbamate, 1 ,1 -dimethylbutyl carbamate,
  • the compound of formula (7) is selected from the group consisting of urea, methyl carbamate, ethyl carbamate, propyl carbamate, 1 -methylethyl carbamate, butyl carbamate, 1 -methylpropyl carbamate, 2-methylpropyl carbamate, 1 ,1 -dimethylethyl carbamate, hexyl carbamate, cyclopropyl carbamate, cyclobutyl carbamate, cyclopentyl carbamate, cyclohexyl carbamate, cyclobutenyl carbamate, 3-oxo-cyclobuten-1-yl carbamate, cyclopentenyl carbamate, cyclohexenyl carbamate, phenyl carbamate, and benzyl carbamate.
  • the compound of formula (7) is selected from the group consisting of urea, 1 ,1- dimethylethyl carbamate, 3-oxo-cyclobuten-1-yl carbamate, cyclohexenyl carbamate, phenyl carbamate, and benzyl carbamate.
  • X is selected from Cl and Br.
  • X is Cl.
  • the compound of formula (2) is reacted with the compound of formula (5), R 1 is methyl, tert-butyl or phenyl, and R 2 is H, and R 3 and R 4 are cyclohexyl.
  • the compound of formula (2) is reacted with the compound of formula (6), R 1 is methyl, tert-butyl, phenyl, tolyl, or benzyl, X is Cl, and R 2 is H, and R 3 and R 4 are cyclohexyl.
  • the compound of formula (2) is reacted with a compound selected from
  • the compound of formula (1) is selected from
  • the compound of formula (2) is reacted with the compound of formula (4), (5), (6), or (7) in the presence of a solvent.
  • the solvent is selected from methyl tertbutyl ether (MTBE), dichloromethane (CH2CI2), deuterated dichloromethane (CD2CI2), tetrahydrofuran (THF), 2-methyltetrahydrofuran (2-MeTHF), and ethyl acetate.
  • the compound of formula (2) is reacted with the compound of formula (4), (5), (6), or (7) at a temperature of from -10°C to 50°C.
  • the compound of formula (2) is reacted with the compound of formula (4), (5), (6), or (7) at a temperature of from 0°C to 30°C.
  • the compound of formula (2) is reacted with the compound of formula (4), (5), (6), or (7) for at least 30 minutes, preferably for at least 1 h., such as at least 1 .5 h, at least 2 h, at least 2.5 h or at least 3 h.
  • the compound of formula (2) is added dropwise to the compound of formula (4), (5), (6), or (7).
  • the compound of formula (2) is contacted with trifluoroacetic acid (TFA) prior to reacting with the compound of formula (4), (5), (6), or (7).
  • TFA trifluoroacetic acid
  • Example 1 The Dion salt (3-hydroxy-2-cyclobuten-1-one dicyclohexylammonium salt, 20.04 g) was suspended in methyl tert-butyl ether (140.04 g) at room temperature (r.t.) under inert atmosphere (Nitrogen) and the obtained suspension was cooled with vigorous stirring on an ice bath. A solution of acetyl chloride (5.98 g) in methyl tert-butyl ether (10.50 g) was added dropwise and the obtained orange suspension was stirred at 0 °C for 2 h and 4 h at r.t. (until the precipitate in suspension became white).
  • the Dion salt (3-hydroxy-2-cyclobuten-1-one dicyclohexylammonium salt, 1.01 g), CH2CI2 (10.08 g), acetic anhydride (0.58 g) and triethylamine (0.46 g) were stirred in a vial at r.t for 24 h. The mixture was filtered and the filtrate was concentrated under vacuum.
  • the Dion salt (3-hydroxy-2-cyclobuten-1-one dicyclohexylammonium salt; 1.00 g) was suspended in CH2CI2 (10.21 g). Methanesulfonyl chloride (0.65 g) and triethylamine (0.47 g) were added to the suspension. The orange-brownish suspension was stirred at room temperature (r.t.) for 24 h. The suspension was filtered. The filtrated was concentrated under vacuum. 1H-NMR: (400 MHz, CDCh) ppm 5.35 (s, 1 H), 3.37 (m, 3H), 3.22 (m, 2H).
  • Example 4 Example 4:
  • the Dion salt (3-hydroxy-2-cyclobuten-1-one dicyclohexylammonium salt; 1.06 g) was suspended in CH2CI2 (10.04 g). Triphosgene (1.21 g) was added at 0°C and stirred for 2 h at 0°C and 2 h at r.t. The suspension was filtered and concentrated. The mono- and disubstituted product was obtained as pale yellow solution (1.36 g).
  • the Dion salt (3-hydroxy-2-cyclobuten-1-one dicyclohexylammonium salt; 10.00 g) was suspended in CH2CI2 (134 g), placed into the phosgene reactor and cooled to 5 °C. Phosgene (1.0 eq.) was dosed over 1 h at 5 °C. The resulting mixture was stirred for 12 h at 5 °C and warmed up to 20 °C and further stirred for 6 h at 20 °C. MeOH (50 g) was dosed at 20 °C for 1 h to quench the reaction. The reaction mixture was concentrated to dryness and the suspension was washed with CH2CI2.
  • the Dion salt (3-hydroxy-2-cyclobuten-1-one dicyclohexylammonium salt; 10.00 g) was suspended in CH2CI2 (134 g), placed into the phosgene reactor and cooled to 5 °C. Phosgene (0.5 eq.) was dosed over 1 h at 5 °C. The resulting mixture was stirred for 12 h at 5 °C and warmed up to 20 °C and further stirred for 6 h at 20 °C. MeOH (50 g) was dosed at 20 °C for 1 h to quench the reaction. The reaction mixture was concentrated to dryness and the suspension was washed with CH2CI2. The filtrated was concentrated under vacuum to obtain the product.
  • Example 7 Example 7:
  • the Dion salt (3-hydroxy-2-cyclobuten-1-one dicyclohexylammonium salt; 1.00 g) was suspended in methyl tert-butyl ether (10 g) at 0 °C. Trifluoroacetic acid (1.1 eq.) was added to the suspension and further stirred at 0 °C for 2 h. The suspension was filtered and the filtrate was mixed with urea (0.5 eq.) at 0 °C. The mixture was heated up to r.t over night. The reaction mixture was concentrated under vacuum to obtain 1 ,3-bis(3-oxocyclobut-1-en-1-yl)urea.
  • the Dion salt (3-hydroxy-2-cyclobuten-1-one dicyclohexylammonium salt; 1.00 g) was suspended in methyl tert-butyl ether (10 g) at 0 °C. Trifluoroacetic acid (1.1 eq.) was added to the suspension and further stirred at 0 °C for 2 h. The suspension was filtered and the filtrate was mixed with tert butyl carbamate (1 eq.) at 0 °C. The mixture was heated up to r.t over night. The reaction mixture was concentrated under vacuum to obtain tert-butyl (3-oxocyclobut-1-en-1-yl)carbamate.
  • Example 9 Example 9:
  • the Dion salt (3-hydroxy-2-cyclobuten-1-one dicyclohexylammonium salt; 1.03 g) was suspended in CH2CI2 (10.22 g). Phenyl chloroformate (0.59 g) was added at 0 °C and stirred for 2 h at 0 °C and 4 h at r.t. The suspension was filtered and concentrated to obtain 3-oxocyclobut-1-en-1-yl phenyl carbonate (0.73 g, 93.9%).
  • Example 10 The Dion salt (3-hydroxy-2-cyclobuten-1-one dicyclohexylammonium salt; 10.00 g) was suspended in CH2CI2 (134 g), placed into the phosgene reactor and cooled to 5 °C. Phosgene (1 .0 eq.) was dosed over 1 h at 5 °C. The resulting mixture was stirred for 12 h at 5 °C and warmed up to 20 °C and further stirred for 6 h at 20 °C. The reaction mixture was concentrated to dryness and the suspension was washed with CH2CI2. The filtrated was concentrated under vacuum to obtain 3- oxocyclobut-1-en-1-yl carbonochloridate.

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

The present invention relates to a process for the preparation of cyclobutenone derivatives of formula (1), wherein Y is O or NH, R is -C(O)-R1 or -S(0)2-R1, and R' is selected from optionally substituted linear or branched C1-12 alkyl, optionally substituted C3-8 cycloalkyl, optionally substituted C3-8 cycloalkenyl, optionally substituted aryl, -NR5R6, - OR7, and halogen, wherein R5, R6, and R7 are each independently selected from H, optionally substituted linear or branched C1-12 alkyl, optionally substituted C3-8 cycloalkyl, optionally substituted C3-8 cycloalkenyl, and optionally substituted aryl.

Description

Process for the preparation of cyclic ketones
Technical Field
The present invention relates to a process for the preparation of cyclobutenone derivatives.
Technological Background
Functionalized cyclobutenone derivatives are valuable intermediates for the production of various compounds such as pharmaceutical and agrochemical agents.
One example of such functionalized cyclobutenone derivatives is 3-acetoxy-2-cyclobuten-1-one (also known as triketene).
Triketene is a side product in the diketene production and is typically obtained by distillation from the distillation residue obtained in the diketene production. The distillation residue from the diketene production, which is also referred to as triketene resin, typically comprises 10% diketene, 30% triketene and 60% undefined compounds. The production of triketene by distillation of triketene resin is disclosed in CH 596 132. However, this method suffers inter alia from the drawback that only triketene and no other functionalized cyclobutenone derivatives can be obtained.
Hence, there is a need for a process with which various cyclobutenone derivatives are accessible. Furthermore, there is an ongoing need for optimized processes for the synthesis of cyclobutenone derivatives.
An object of the present invention is to provide an excellent process for the synthesis of cyclobutenone derivatives. A further object of the present invention is to provide a process which provides various cyclobutenone derivatives. Summary of the invention
In one aspect, the present invention provides a process for the preparation of a compound of formula (1)
Figure imgf000003_0001
wherein
Y is O or NH,
R is -C(O)-R1 or -S(0)2-R1, and
R1 is selected from optionally substituted linear or branched C1-12 alkyl, optionally substituted C3-8 cycloalkyl, optionally substituted C3-8 cycloalkenyl, optionally substituted aryl, -NR5R6, -OR7, and halogen, wherein R5, R6, and R7 are each independently selected from H, optionally substituted linear or branched C1-12 alkyl, optionally substituted C3-8 cycloalkyl, optionally substituted C3-8 cycloalkenyl, and optionally substituted aryl; the process comprising reacting a compound of formula (2)
A+
Figure imgf000003_0002
wherein A+ is an ammonium group of formula (3)
Figure imgf000003_0003
wherein R2, R3, and R4 are each independently selected from H, optionally substituted linear or branched C1-12 alkyl, and optionally substituted C3-8 cycloalkyl, with a compound of formula (4), (5), (6), or (7)
Figure imgf000004_0001
wherein X is selected from F, Cl, Br, or I, wherein the process excludes reacting 3-hydroxy-2-cyclobuten-1-one dicyclohexylammonium salt with trimethylacetyl chloride.
Detailed description of the invention
In the following, the invention will be explained in more detail.
According to the present invention, the term “linear or branched C1-12 alkyl” refers to a straight- chained or branched saturated hydrocarbon group having 1 to 12 carbon atoms, such as 1 , 2, 3, 4, 5, 6, 7, 8, 9, 10, 11 or 12 carbon atoms. Likewise, the term “linear or branched C1-6 alkyl” refers to a straight-chained or branched saturated hydrocarbon group having 1 to 6 carbon atoms (i.e. 1 , 2, 3, 4, 5, or 6 carbon atoms) including methyl, ethyl, propyl, 1 -methylethyl, butyl, 1 -methylpropyl, 2- methylpropyl, 1 ,1-dimethylethyl, pentyl, 1 -methylbutyl, 2-methylbutyl, 3-methylbutyl, 2,2- dimethylpropyl, 1 -ethylpropyl, 1 ,1 -dimethylpropyl, 1 ,2-dimethylpropyl, hexyl, 1 -methylpentyl, 2- methylpentyl, 3-methylpentyl, 4-methylpentyl, 1 ,1-dimethylbutyl, 1 ,2-dimethylbutyl, 1 ,3- dimethylbutyl, 2,2-dimethylbutyl, 2,3-dimethylbutyl, 3,3-dimethylbutyl, 1 -ethylbutyl, 2-ethylbutyl, 1 ,1 ,2-trimethyl propyl, 1 ,2,2-trimethylpropyl, 1-ethyl-1 -methylpropyl and 1-ethyl-2-methylpropyl.
According to the present invention, the term “C3-8 cycloalkyl” refers to monocyclic saturated hydrocarbon groups having 3 to 8 carbon ring members (i.e. 1 , 2, 3, 4, 5, 6, 7, or 8 carbon atoms) including cyclopropyl, cyclobutyl, cyclopentyl, cyclohexyl, cycloheptyl, and cyclooctyl. Likewise, the term “C3-6 cycloalkyl” refers to monocyclic saturated hydrocarbon radicals having 3 to 6 carbon ring members (i.e. 1 , 2, 3, 4, 5, or 6 carbon atoms) including cyclopropyl, cyclobutyl, cyclopentyl, and cyclo hexyl.
According to the present invention, the term “C3-8 cycloalkenyl” refers to monocyclic alkene hydrocarbon groups having 3 to 8 carbon ring members (i.e. 1 , 2, 3, 4, 5, 6, 7, or 8 carbon atoms) that include at least one carbon-carbon double bond in the ring of carbon atoms. Exemplary “C3-8 cycloalkenyl” include cyclopropenyl, cyclobutenyl, cyclopentenyl, cyclohexenyl, cycloheptenyl, 1 ,3- cyclohexadienyl, 1 ,4-cyclohexadienyl, 1 ,5-cyclooctadienyl, cis-cyclooctenyl, and trans-cyclooctenyl.
According to the present invention, the term “aryl” refers to refers to both single-ring aromatic hydrocarbyl groups and polycyclic aromatic ring systems. The polycyclic rings may have two or more rings in which two carbons are common to two adjoining rings (the rings are "fused") wherein at least one of the rings is an aromatic hydrocarbyl group, e.g., the other rings can be cycloalkyls, cycloalkenyls, aryl, heterocycles, and/or heteroaryls. Preferred aryl groups are those containing six to twelve carbon atoms. Especially preferred is an aryl group having six carbons, ten carbons or twelve carbons. Suitable aryl groups include phenyl, biphenyl, triphenyl, triphenylene, tetraphenylene, naphthalene, anthracene, phenalene, phenanthrene, fluorene, pyrene, chrysene, perylene, and azulene, preferably phenyl, biphenyl, triphenyl, triphenylene, fluorene, and naphthalene.
It is to be understood that the linear or branched C1-12 alkyl, C3-8 cycloalkyl, C3-8 cycloalkenyl and aryl may optionally be further substituted. Exemplary substituents include hydroxy, oxo (=O), linear or branched C1-12 alkyl, C3-8 cycloalkyl, C3-8 cycloalkenyl, a carboxy group, halogen, and aryl.
According to the present invention, the term “halogen” refers to fluorine, chlorine, bromine and iodine.
It is to be understood that the term “tolyl” includes o-tolyl, m-tolyl, and p-tolyl.
As outlined above, subject of the present invention is a process for the preparation of a compound of formula (1)
Figure imgf000005_0001
wherein
Y is O or NH,
R is -C(O)-R1 or -S(0)2-R1, and
R1 is selected from optionally substituted linear or branched C1-12 alkyl, optionally substituted C3-8 cycloalkyl, optionally substituted C3-8 cycloalkenyl, optionally substituted aryl, -NR5R6, -OR7, and halogen, wherein R5, R6, and R7 are each independently selected from H, optionally substituted linear or branched C1-12 alkyl, optionally substituted C3-8 cycloalkyl, optionally substituted C3-8 cycloalkenyl, and optionally substituted aryl; the process comprising reacting a compound of formula (2)
Figure imgf000006_0001
wherein A+ is an ammonium group of formula (3)
Figure imgf000006_0002
wherein R2, R3, and R4 are each independently selected from H, optionally substituted linear or branched C1-12 alkyl, and optionally substituted C3-8 cycloalkyl, with a compound of formula (4), (5), (6), or (7)
Figure imgf000006_0003
wherein X is selected from F, Cl, Br, or I, wherein the process excludes reacting 3-hydroxy-2-cyclobuten-1-one dicyclohexylammonium salt with trimethylacetyl chloride.
The inventive process provides an excellent route for the preparation of compounds of formula (1). Particularly, it has been surprisingly found that the inventive process is atom efficient and produces low amounts of waste. Furthermore, with the inventive process for the preparation of compounds of formula (1) various cyclobutenone derivatives are accessible. Reacting a compound of formula (2) also has the advantage that different reactions are possible and cyclobutenone derivatives of formula (1) are accessible. Moreover, the inventors surprisingly found that with the inventive process for the preparation of compounds of formula (1), various cyclobutenone derivatives are obtainable without the use of a catalyst.
In one embodiment, R1 is selected from optionally substituted linear or branched Ci-e alkyl, optionally substituted C3-8 cycloalkyl, optionally substituted C3-8 cycloalkenyl, phenyl, benzyl, tolyl, - NR5R6, -OR7, and halogen. In one embodiment, R1 is selected from optionally substituted linear or branched C1-6 alkyl, optionally substituted C3-6 cycloalkyl, phenyl benzyl, tolyl, -NR5R6, -OR7, and halogen.
In one embodiment, R1 is selected from methyl, ethyl, propyl, 1 -methylethyl, butyl, 1 -methylpropyl, 2-methylpropyl, tert-butyl, pentyl, hexyl, cyclopropyl, cyclobutyl, cyclopentyl, cyclohexyl, phenyl, tolyl, and benzyl.
Preferably, R1 is methyl, tert-butyl, phenyl, tolyl, or benzyl.
In one embodiment, R is -C(O)-R1 and R1 is selected from -NR5R6, -OR7, and halogen, Preferably, R5 is H and R6 and R7 are optionally substituted C3-8 cycloalkenyl, More preferably, R5 is H and R6 and R7 are 3-oxo-cyclobuten-1-yl. Preferably, halogen is Cl or Br, more preferably Cl.
In one embodiment, R is -C(O)-R1 and R1 is -OR7. In one embodiment, R is -C(O)-R1 and R1 is - OR7 and R7 is 3-oxo-cyclobuten-1-yl or methyl.
In one embodiment, R is -C(O)-R1 and R1 is-NR5R6. In one embodiment, R is -C(O)-R1 and R1 is- NR5R6 and R5 is H and R6 is 3-oxo-cyclobuten-1-yl. In one embodiment, in the ammonium group of formula (3), R2 is H, and R3 and R4 are each independently selected from optionally substituted linear or branched C1-12 alkyl, and optionally substituted C3-8 cycloalkyl.
Preferably, R2 is H, and R3 and R4 are cyclohexyl.
Preferably, the compound of formula (2) is 3-hydroxy-2-cyclobuten-1-one dicyclohexylammonium salt, depicted by the following formula:
Figure imgf000008_0001
In one embodiment, the compound of formula (4) is selected from the group consisting of acetyl chloride, acetyl bromide, propionyl chloride, propionyl bromide, butyryl chloride, butyryl bromide, isobutyryl chloride, isobutyryl bromide, trimethylacetyl chloride, trimethylacetyl bromide, tertbutylacetyl chloride, tert-butylacetyl bromide, benzoyl chloride, benzoyl bromide, phosgene, methyl chloroform ate, ethyl chloroformate, propyl chloroformate, 1 -methylethyl chloroform ate, butyl chloroform ate, 1 -methylpropyl chloroform ate, 2-methylpropyl chloroform ate, 1 ,1 -dimethylethyl chloroform ate, pentyl chloroform ate, 1 -methylbutyl chloroformate, 2-methylbutyl chloroform ate, 3- methylbutyl chloroform ate, 2,2-dimethylpropyl chloroform ate, 1 -ethylpropyl chloroform ate, 1 ,1- dimethylpropyl chloroform ate, 1 ,2-dimethylpropyl chloroformate, hexyl chloroform ate, 1- methylpentyl chloroformate, 2-methylpentyl chloroformate, 3-methylpentyl chloroform ate, 4- methylpentyl chloroformate, 1 ,1 -dimethylbutyl chloroform ate, 1 ,2-dimethylbutyl chloroform ate, 1 ,3- dimethylbutyl chloroform ate, 2,2-dimethylbutyl chloroform ate, 2,3-dimethylbutyl chloroform ate, 3,3-dimethylbutyl chloroformate, 1-ethylbutyl chloroform ate, 2-ethylbutyl chloroformate, 1 ,1 ,2- trimethyl propyl chloroform ate, 1 ,2,2-trimethylpropyl chloroform ate, 1 -ethyl-1 -methylpropyl chloroform ate, 1-ethyl-2-methylpropyl chloroform ate, cyclopropyl chloroformate, cyclobutyl chloroform ate, cyclopentyl chloroformate, cyclohexyl chloroform ate, cycloheptyl chloroformate, cyclooctyl chloroform ate, cyclopropenyl chloroformate, cyclobutenyl chloroform ate, 3-oxo- cyclobuten-1-yl chloroform ate, cyclopentenyl chloroform ate, cyclohexenyl chloroform ate, cycloheptenyl chloroform ate, 1 ,3-cyclohexadienyl chloroform ate, 1 ,4-cyclohexadienyl chloroform ate, 1 ,5-cyclooctadienyl chloroform ate, cis-cyclooctenyl chloroformate, trans-cyclooctenyl chloroformate, phenyl chloroformate, benzyl chloroform ate, methyl bromoformate, ethyl bromoformate, propyl bromoformate, 1 -methylethyl bromoformate, butyl bromoformate, 1 -methylpropyl bromoformate, 2- methylpropyl bromoformate, 1 ,1 -dimethylethyl bromoformate, pentyl bromoformate, 1-methylbutyl bromoformate, 2-methylbutyl bromoformate, 3-methylbutyl bromoformate, 2,2-dimethylpropyl bromoformate, 1 -ethylpropyl bromoformate, 1 ,1 -dimethylpropyl bromoformate, 1 ,2-dimethylpropyl bromoformate, hexyl bromoformate, 1 -methylpentyl bromoformate, 2-methylpentyl bromoformate, 3- methylpentyl bromoformate, 4-methylpentyl bromoformate, 1 ,1 -dimethylbutyl bromoformate, 1 ,2- dimethylbutyl bromoformate, 1 ,3-dimethylbutyl bromoformate, 2,2-dimethylbutyl bromoformate, 2,3- dimethylbutyl bromoformate, 3,3-dimethylbutyl bromoformate, 1 -ethylbutyl bromoformate, 2- ethylbutyl bromoformate, 1 ,1 ,2-trimethyl propyl bromoformate, 1 ,2,2-trimethylpropyl bromoformate, 1-ethyl-1 -methylpropyl bromoformate, 1-ethyl-2-methylpropyl bromoformate, cyclopropyl bromoformate, cyclobutyl bromoformate, cyclopentyl bromoformate, cyclohexyl bromoformate, cycloheptyl bromoformate, cyclooctyl bromoformate, cyclopropenyl bromoformate, cyclobutenyl bromoformate, 3-oxo-cyclobuten-1-yl bromoformate, cyclopentenyl bromoformate, cyclohexenyl bromoformate, cycloheptenyl bromoformate, 1 ,3-cyclohexadienyl bromoformate, 1 ,4- cyclohexadienyl bromoformate, 1 ,5-cyclooctadienyl bromoformate, cis-cyclooctenyl bromoformate, trans-cyclooctenyl bromoformate, phenyl bromoformate, and benzyl bromoformate.
Preferably, the compound of formula (4) is selected from the group consisting of acetyl chloride, acetyl bromide, trimethylacetyl chloride, trimethylacetyl bromide, benzoyl chloride, benzoyl bromide, phosgene, 3-oxo-cyclobuten-1-yl chloroform ate, 3-oxo-cyclobuten-1-yl bromoformate, cyclohexenyl chloroform ate, cyclohexenyl bromoformate, phenyl chloroformate, phenyl bromoformate, benzyl chloroform ate, and benzyl bromoformate.
In one embodiment, the compound of formula (4) is selected from the group consisting of acetyl chloride, propionyl chloride, butyryl chloride, isobutyryl chloride, trimethylacetyl chloride, tertbutylacetyl chloride, benzoyl chloride, phosgene, 3-oxo-cyclobuten-1-yl chloroform ate, cyclohexenyl chloroform ate, phenyl chloroform ate, and benzyl chloroformate.
Preferably, the compound of formula (4) is selected from the group consisting of acetyl chloride, trimethylacetyl chloride, benzoyl chloride, phosgene, and 3-oxo-cyclobuten-1-yl chloroform ate.
In one embodiment, the compound of formula (4) is selected from the group consisting of acetyl bromide, propionyl bromide, butyryl bromide, isobutyryl bromide, trimethylacetyl bromide, tertbutylacetyl bromide, benzoyl bromide, phosgene, 3-oxo-cyclobuten-1-yl bromoformate, cyclohexenyl bromoformate, phenyl bromoformate, and benzyl bromoformate. Preferably, the compound of formula (4) is selected from the group consisting of acetyl bromide, trimethylacetyl bromide, benzoyl bromide, phosgene, and 3-oxo-cyclobuten-1-yl bromoformate.
The inventive process does not encompass reacting 3-hydroxy-2-cyclobuten-1-one dicyclohexylammonium salt as the compound of formula (2) with trimethylacetyl chloride (compound of formula (4)) to obtain 3-oxocyclobut-1-en-1-yl pivalate (compound of formula (1)).
In one embodiment, the compound of formula (5) is selected from the group consisting of triphosgene, acetic anhydride, propanoic anhydride, butyric anhydride, isobutyric anhydride, trimethylacetic anhydride, benzoic anhydride and cyclopropanecarboxylic acid anhydride. Preferably, the compound of formula (5) is acetic anhydride.
In one embodiment, the compound of formula (6) is selected from the group consisting of methanesulfonyl chloride, methanesulfonyl bromide, ethanesulfonyl chloride, ethanesulfonyl bromide, 1 -propanesulfonyl chloride, 1 -propanesulfonyl bromide, 2-propanesulfonyl chloride, 3- propanesulfonyl bromide, butanesulfonyl chloride, butanesulfonyl bromide, butane-2-sulfonyl chloride, butane-2-sulfonyl bromide, 2-methyl-2-propanesulfonyl chloride, 2-methyl-2- propanesulfonyl bromide, benzenesulfonyl chloride, benzenesulfonyl bromide, toluenesulfonyl chloride, and toluenesulfonyl bromide.
Preferably, toluenesulfonyl chloride is p-toluenesulfonyl chloride. Preferably, toluenesulfonyl bromide is p-toluenesulfonyl bromide.
In one embodiment, the compound of formula (6) is selected from the group consisting of methanesulfonyl chloride, ethanesulfonyl chloride, 1 -propanesulfonyl chloride, 2-propanesulfonyl chloride, butanesulfonyl chloride, butane-2-sulfonyl chloride, 2-methyl-2-propanesulfonyl chloride, benzenesulfonyl chloride, and toluenesulfonyl chloride.
In one embodiment, the compound of formula (6) is selected from the group consisting of methanesulfonyl bromide, ethanesulfonyl bromide, 1 -propanesulfonyl bromide, 2-propanesulfonyl bromide, butanesulfonyl bromide, butane-2-sulfonyl bromide, 2-methyl-2-propanesulfonyl bromide, benzenesulfonyl bromide, and toluenesulfonyl bromide.
In one embodiment, the compound of formula (7) is selected from the group consisting of urea, methyl carbamate, ethyl carbamate, propyl carbamate, 1 -methylethyl carbamate, butyl carbamate, 1 -methylpropyl carbamate, 2-methylpropyl carbamate, 1 ,1 -dimethylethyl carbamate, pentyl carbamate, 1 -methylbutyl carbamate, 2-methylbutyl carbamate, 3-methylbutyl carbamate, 2,2- dimethylpropyl carbamate, 1 -ethylpropyl carbamate, 1 ,1 -dimethylpropyl carbamate, 1 ,2- dimethylpropyl carbamate, hexyl carbamate, 1 -methylpentyl carbamate, 2-methylpentyl carbamate, 3-methylpentyl carbamate, 4-methylpentyl carbamate, 1 ,1 -dimethylbutyl carbamate, 1 ,2- dimethylbutyl carbamate, 1 ,3-dimethylbutyl carbamate, 2,2-dimethylbutyl carbamate, 2,3- dimethylbutyl carbamate, 3,3-dimethylbutyl carbamate, 1 -ethylbutyl carbamate, 2-ethylbutyl carbamate, 1 ,1 ,2-trimethyl propyl carbamate, 1 ,2,2-trimethylpropyl carbamate, 1-ethyl-1- methylpropyl carbamate, 1-ethyl-2-methylpropyl carbamate, cyclopropyl carbamate, cyclobutyl carbamate, cyclopentyl carbamate, cyclohexyl carbamate, cycloheptyl carbamate, cyclooctyl carbamate, cyclopropenyl carbamate, cyclobutenyl carbamate, 3-oxo-cyclobuten-1-yl carbamate, cyclopentenyl carbamate, cyclohexenyl carbamate, cycloheptenyl carbamate, 1 ,3-cyclohexadienyl carbamate, 1 ,4-cyclohexadienyl carbamate, 1 ,5-cyclooctadienyl carbamate, cis-cyclooctenyl carbamate, trans-cyclooctenyl carbamate, phenyl carbamate, and benzyl carbamate.
In one embodiment, the compound of formula (7) is selected from the group consisting of urea, methyl carbamate, ethyl carbamate, propyl carbamate, 1 -methylethyl carbamate, butyl carbamate, 1 -methylpropyl carbamate, 2-methylpropyl carbamate, 1 ,1 -dimethylethyl carbamate, hexyl carbamate, cyclopropyl carbamate, cyclobutyl carbamate, cyclopentyl carbamate, cyclohexyl carbamate, cyclobutenyl carbamate, 3-oxo-cyclobuten-1-yl carbamate, cyclopentenyl carbamate, cyclohexenyl carbamate, phenyl carbamate, and benzyl carbamate.
Preferably, the compound of formula (7) is selected from the group consisting of urea, 1 ,1- dimethylethyl carbamate, 3-oxo-cyclobuten-1-yl carbamate, cyclohexenyl carbamate, phenyl carbamate, and benzyl carbamate.
In one embodiment, X is selected from Cl and Br. Preferably X is Cl.
An exemplary reaction of the compound of formula (2) with a compound of formula (4) is shown in the following:
Figure imgf000011_0001
In one embodiment, the compound of formula (2) is reacted with the compound of formula (4), R1 is methyl or phenyl, X is Cl, and R2 is H, and R3 and R4 are cyclohexyl.
An exemplary reaction of the compound of formula (2) with a compound of formula (5) is shown in the following:
Figure imgf000012_0001
In one embodiment, the compound of formula (2) is reacted with the compound of formula (5), R1 is methyl, tert-butyl or phenyl, and R2 is H, and R3 and R4 are cyclohexyl.
An exemplary reaction of the compound of formula (2) with a compound of formula (6) is shown in the following:
Figure imgf000012_0002
In one embodiment, the compound of formula (2) is reacted with the compound of formula (6), R1 is methyl, tert-butyl, phenyl, tolyl, or benzyl, X is Cl, and R2 is H, and R3 and R4 are cyclohexyl.
In one embodiment, the compound of formula (2) is reacted with a compound selected from
Figure imgf000013_0001
In one embodiment, the compound of formula (1) is selected from
Figure imgf000014_0001
In one embodiment, the compound of formula (2) is reacted with the compound of formula (4), (5), (6), or (7) in the presence of a solvent. In one embodiment, the solvent is selected from methyl tertbutyl ether (MTBE), dichloromethane (CH2CI2), deuterated dichloromethane (CD2CI2), tetrahydrofuran (THF), 2-methyltetrahydrofuran (2-MeTHF), and ethyl acetate.
In one embodiment, the compound of formula (2) is reacted with the compound of formula (4), (5), (6), or (7) at a temperature of from -10°C to 50°C. Preferably, the compound of formula (2) is reacted with the compound of formula (4), (5), (6), or (7) at a temperature of from 0°C to 30°C.
In one embodiment, the compound of formula (2) is reacted with the compound of formula (4), (5), (6), or (7) for at least 30 minutes, preferably for at least 1 h., such as at least 1 .5 h, at least 2 h, at least 2.5 h or at least 3 h.
In one embodiment, the compound of formula (2) is added dropwise to the compound of formula (4), (5), (6), or (7).
In one embodiment, the compound of formula (2) is contacted with trifluoroacetic acid (TFA) prior to reacting with the compound of formula (4), (5), (6), or (7).
It will be obvious for a person skilled in the art that these embodiments and items only depict examples of a plurality of possibilities. Hence, the embodiments shown here should not be understood to form a limitation of these features and configurations. Any possible combination and configuration of the described features can be chosen according to the scope of the invention.
The present invention will be further illustrated by the following examples.
Examples
Example 1 :
Figure imgf000015_0001
The Dion salt (3-hydroxy-2-cyclobuten-1-one dicyclohexylammonium salt, 20.04 g) was suspended in methyl tert-butyl ether (140.04 g) at room temperature (r.t.) under inert atmosphere (Nitrogen) and the obtained suspension was cooled with vigorous stirring on an ice bath. A solution of acetyl chloride (5.98 g) in methyl tert-butyl ether (10.50 g) was added dropwise and the obtained orange suspension was stirred at 0 °C for 2 h and 4 h at r.t. (until the precipitate in suspension became white). Filtration and washing of the precipitate with methyl tert-butyl ether (50.4 g) afforded 3- oxocyclobut-1-en-1-yl acetate as an orange in solution in methyl tert-butyl ether. A small sample was concentrated under reduced pressure at r.t. to measure a NMR-spectra. 1H-NMR: (400 MHz, CDCh) ppm 5.46 (s, 1 H), 3.31 (m, 2H), 2.26 (s, 3H).
Example 2:
Figure imgf000016_0001
The Dion salt (3-hydroxy-2-cyclobuten-1-one dicyclohexylammonium salt, 1.01 g), CH2CI2 (10.08 g), acetic anhydride (0.58 g) and triethylamine (0.46 g) were stirred in a vial at r.t for 24 h. The mixture was filtered and the filtrate was concentrated under vacuum.
Example 3:
Figure imgf000016_0002
The Dion salt (3-hydroxy-2-cyclobuten-1-one dicyclohexylammonium salt; 1.00 g) was suspended in CH2CI2 (10.21 g). Methanesulfonyl chloride (0.65 g) and triethylamine (0.47 g) were added to the suspension. The orange-brownish suspension was stirred at room temperature (r.t.) for 24 h. The suspension was filtered. The filtrated was concentrated under vacuum. 1H-NMR: (400 MHz, CDCh) ppm 5.35 (s, 1 H), 3.37 (m, 3H), 3.22 (m, 2H). Example 4:
Figure imgf000017_0001
The Dion salt (3-hydroxy-2-cyclobuten-1-one dicyclohexylammonium salt; 1.06 g) was suspended in CH2CI2 (10.04 g). Triphosgene (1.21 g) was added at 0°C and stirred for 2 h at 0°C and 2 h at r.t. The suspension was filtered and concentrated. The mono- and disubstituted product was obtained as pale yellow solution (1.36 g). 1H-NMR: (400 MHz, CDCh) ppm 5.19 (s, 1 H), 3.43 (m, 2H).
Example 5:
Figure imgf000017_0002
The Dion salt (3-hydroxy-2-cyclobuten-1-one dicyclohexylammonium salt; 10.00 g) was suspended in CH2CI2 (134 g), placed into the phosgene reactor and cooled to 5 °C. Phosgene (1.0 eq.) was dosed over 1 h at 5 °C. The resulting mixture was stirred for 12 h at 5 °C and warmed up to 20 °C and further stirred for 6 h at 20 °C. MeOH (50 g) was dosed at 20 °C for 1 h to quench the reaction. The reaction mixture was concentrated to dryness and the suspension was washed with CH2CI2.
The filtrated was concentrated under vacuum to obtain methyl (3-oxocyclobut-1-en-1-yl) carbonate. Example 6:
Figure imgf000017_0003
The Dion salt (3-hydroxy-2-cyclobuten-1-one dicyclohexylammonium salt; 10.00 g) was suspended in CH2CI2 (134 g), placed into the phosgene reactor and cooled to 5 °C. Phosgene (0.5 eq.) was dosed over 1 h at 5 °C. The resulting mixture was stirred for 12 h at 5 °C and warmed up to 20 °C and further stirred for 6 h at 20 °C. MeOH (50 g) was dosed at 20 °C for 1 h to quench the reaction. The reaction mixture was concentrated to dryness and the suspension was washed with CH2CI2. The filtrated was concentrated under vacuum to obtain the product. Example 7:
Figure imgf000018_0001
The Dion salt (3-hydroxy-2-cyclobuten-1-one dicyclohexylammonium salt; 1.00 g) was suspended in methyl tert-butyl ether (10 g) at 0 °C. Trifluoroacetic acid (1.1 eq.) was added to the suspension and further stirred at 0 °C for 2 h. The suspension was filtered and the filtrate was mixed with urea (0.5 eq.) at 0 °C. The mixture was heated up to r.t over night. The reaction mixture was concentrated under vacuum to obtain 1 ,3-bis(3-oxocyclobut-1-en-1-yl)urea.
Example 8:
Figure imgf000018_0002
The Dion salt (3-hydroxy-2-cyclobuten-1-one dicyclohexylammonium salt; 1.00 g) was suspended in methyl tert-butyl ether (10 g) at 0 °C. Trifluoroacetic acid (1.1 eq.) was added to the suspension and further stirred at 0 °C for 2 h. The suspension was filtered and the filtrate was mixed with tert butyl carbamate (1 eq.) at 0 °C. The mixture was heated up to r.t over night. The reaction mixture was concentrated under vacuum to obtain tert-butyl (3-oxocyclobut-1-en-1-yl)carbamate. Example 9:
Figure imgf000019_0001
The Dion salt (3-hydroxy-2-cyclobuten-1-one dicyclohexylammonium salt; 1.03 g) was suspended in CH2CI2 (10.22 g). Phenyl chloroformate (0.59 g) was added at 0 °C and stirred for 2 h at 0 °C and 4 h at r.t. The suspension was filtered and concentrated to obtain 3-oxocyclobut-1-en-1-yl phenyl carbonate (0.73 g, 93.9%). 1H-NMR: (400 MHz, CDCh) ppm 7.35 (m, 2H), 7.24 (m, 1 H), 7.16 (m, 2H), 5.50 (s, 1 H), 3.39 (d, 2H).
Example 10:
Figure imgf000019_0002
The Dion salt (3-hydroxy-2-cyclobuten-1-one dicyclohexylammonium salt; 10.00 g) was suspended in CH2CI2 (134 g), placed into the phosgene reactor and cooled to 5 °C. Phosgene (1 .0 eq.) was dosed over 1 h at 5 °C. The resulting mixture was stirred for 12 h at 5 °C and warmed up to 20 °C and further stirred for 6 h at 20 °C. The reaction mixture was concentrated to dryness and the suspension was washed with CH2CI2. The filtrated was concentrated under vacuum to obtain 3- oxocyclobut-1-en-1-yl carbonochloridate.

Claims

Claims A process for the preparation of a compound of formula (1)
Figure imgf000020_0001
wherein
Y is O or NH,
R is -C(O)-R1 or -S(0)2-R1, and
R1 is selected from optionally substituted linear or branched C1-12 alkyl, optionally substituted C3-8 cycloalkyl, optionally substituted C3-8 cycloalkenyl, optionally substituted aryl, -NR5R6, -OR7, and halogen, wherein R5, R6, and R7 are each independently selected from H, optionally substituted linear or branched C1-12 alkyl, optionally substituted C3-8 cycloalkyl, optionally substituted C3-8 cycloalkenyl, and optionally substituted aryl,; the process comprising reacting a compound of formula (2)
A+
Figure imgf000020_0002
wherein A+ is an ammonium group of formula (3)
R2
R3 N-H
R4
(3) wherein R2, R3, and R4 are each independently selected from H, optionally substituted linear or branched C1-12 alkyl, and optionally substituted C3-8 cycloalkyl, with a compound of formula (4), (5), (6), or (7)
Figure imgf000021_0001
wherein X is selected from F, Cl, Br, or I, wherein the process excludes reacting 3-hydroxy-2-cyclobuten-1-one dicyclohexylammonium salt with trimethylacetyl chloride.
2. The process according to claim 1 , wherein R1 is selected from optionally substituted linear or branched C1-6 alkyl, optionally substituted C3-8 cycloalkyl, optionally substituted C3-8 cycloalkenyl, phenyl, tolyl, benzyl, -NR5R6, -OR7, and halogen.
3. The process according to claim 1 or 2, wherein R1 is selected from methyl, tert-butyl, phenyl, tolyl, benzyl, -NR5R6, -OR7, and halogen.
4. The process according to any one of claims 1 to 3, wherein R2 is H, and R3 and R4 are each independently selected from optionally substituted linear or branched C1-12 alkyl, and optionally substituted C3-8 cycloalkyl.
5. The process according to any one of claims 1 to 4, wherein R2 is H, and R3 and R4 are cyclo hexyl.
6. The process according to any one of claims 1 to 5, wherein R is -C(O)-R1 and R1 is selected from -NR5R6, -OR7, and halogen.
7. The process according to any one of claims 1 to 6, wherein R5 is H and R6 and R7 are optionally substituted C3-8 cycloalkenyl.
8. The process according to any one of claims 1 to 7, wherein R5 is H and R6 and R7 are 3- oxo-cyclobuten-1-yl or methyl. The process according to any one of claims 1 to 8, wherein the compound of formula (4) is selected from the group consisting of acetyl chloride, propionyl chloride, butyryl chloride, isobutyryl chloride, trimethylacetyl chloride, tert-butylacetyl chloride, benzoyl chloride, phosgene, 3-oxo-cyclobuten-1-yl chloroform ate, cyclohexenyl chloroform ate, phenyl chloroform ate, benzyl chloroform ate, acetyl bromide, propionyl bromide, butyryl bromide, isobutyryl bromide, trimethylacetyl bromide, tert-butylacetyl bromide, benzoyl bromide, 3- oxo-cyclobuten-1-yl bromoformate, cyclohexenyl bromoformate, phenyl bromoformate, and benzyl bromoformate. The process according to any one of claims 1 to 9, wherein the compound of formula (5) is selected from the group consisting of triphosgene, acetic anhydride, propanoic anhydride, butyric anhydride, isobutyric anhydride, trimethylacetic anhydride, benzoic anhydride and cyclopropanecarboxylic acid anhydride, preferably wherein the compound of formula (5) is acetic anhydride. The process according to any one of claims 1 to 10, wherein the compound of formula (6) is selected from the group consisting of methanesulfonyl chloride, methanesulfonyl bromide, ethanesulfonyl chloride, ethanesulfonyl bromide, 1 -propanesulfonyl chloride, 1- propanesulfonyl bromide, 2-propanesulfonyl chloride, 3-propanesulfonyl bromide, butanesulfonyl chloride, butanesulfonyl bromide, butane-2-sulfonyl chloride, butane-2- sulfonyl bromide, 2-methyl-2-propanesulfonyl chloride, 2-methyl-2-propanesulfonyl bromide, benzenesulfonyl chloride, benzenesulfonyl bromide, toluenesulfonyl chloride, and toluenesulfonyl bromide. The process according to any one of claims 1 to 11 , wherein the compound of formula (7) is selected from the group consisting of urea, methyl carbamate, ethyl carbamate, propyl carbamate, 1 -methylethyl carbamate, butyl carbamate, 1 -methylpropyl carbamate, 2- methylpropyl carbamate, 1 ,1 -dimethylethyl carbamate, hexyl carbamate, cyclopropyl carbamate, cyclobutyl carbamate, cyclopentyl carbamate, cyclohexyl carbamate, cyclobutenyl carbamate, 3-oxo-cyclobuten-1-yl carbamate, cyclopentenyl carbamate, cyclohexenyl carbamate, phenyl carbamate, and benzyl carbamate. The process according to any one of claims 1 to 12, wherein X is selected from Cl and Br, preferably wherein X is Cl. The process according to any one of claims 1 to 13, wherein the compound of formula (2) is reacted with a compound selected from
Figure imgf000023_0001
The process according to any one of claims 1 to 14, wherein the compound of formula (1) is selected from
Figure imgf000024_0001
PCT/EP2023/080263 2022-10-31 2023-10-30 Process for the preparation of cyclic ketones WO2024094637A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP22204830.8 2022-10-31
EP22204830 2022-10-31

Publications (1)

Publication Number Publication Date
WO2024094637A1 true WO2024094637A1 (en) 2024-05-10

Family

ID=88647296

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP2023/080263 WO2024094637A1 (en) 2022-10-31 2023-10-30 Process for the preparation of cyclic ketones

Country Status (1)

Country Link
WO (1) WO2024094637A1 (en)

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH596132A5 (en) 1975-11-11 1978-02-28 Lonza Ag 3-Acetoxy-cyclo:butanone prodn.
EP0444563A2 (en) * 1990-02-26 1991-09-04 Lonza Ag 3-Hydroxy-2-cyclobuten-1-on salts, their preparation and use
WO2008128919A2 (en) * 2007-04-19 2008-10-30 Ucb Pharma S.A. Histamine h3 receptor ligands comprising a cyclobutoxy group

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH596132A5 (en) 1975-11-11 1978-02-28 Lonza Ag 3-Acetoxy-cyclo:butanone prodn.
EP0444563A2 (en) * 1990-02-26 1991-09-04 Lonza Ag 3-Hydroxy-2-cyclobuten-1-on salts, their preparation and use
WO2008128919A2 (en) * 2007-04-19 2008-10-30 Ucb Pharma S.A. Histamine h3 receptor ligands comprising a cyclobutoxy group

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
KOHNEN A L ET AL: "[2+2] Cycloaddition of ketenes with ynamides. A general method for the synthesis of 3-aminocyclobutenone derivatives", TETRAHEDRON, ELSEVIER SIENCE PUBLISHERS, AMSTERDAM, NL, vol. 62, no. 16, 17 April 2006 (2006-04-17), pages 3815 - 3822, XP025001809, ISSN: 0040-4020, [retrieved on 20060417], DOI: 10.1016/J.TET.2005.11.088 *
WASSERMAN H., PIPER J.U.: "Cyclobutenone Derivatives from Ethoxyacetylene Cyclobutenone Derivatives from Ethoxyacetylene1", vol. 38, no. 8, 1 January 1973 (1973-01-01), pages 1451 - 1455, XP093034894, Retrieved from the Internet <URL:https://pubs.acs.org/doi/10.1021/jo00948a003> [retrieved on 20230327], DOI: 10.1021/jo00948a003 *
YU WAN-LEI ET AL: "Cobalt-catalyzed chemoselective dehydrogenation through radical translocation under visible light", CHEMICAL SCIENCE, vol. 13, no. 26, 1 January 2022 (2022-01-01), United Kingdom, pages 7947 - 7954, XP093035006, ISSN: 2041-6520, DOI: 10.1039/D2SC02291E *

Similar Documents

Publication Publication Date Title
IE871960L (en) Optically active benzene sulphonamides.
Erb et al. Application of the Curtius rearrangement to the synthesis of 1′-aminoferrocene-1-carboxylic acid derivatives
WO2024094637A1 (en) Process for the preparation of cyclic ketones
Schönecker et al. A nickelacycle as propionic acid equivalent for carbon-carbon coupling reactions; application to the synthesis of C25 steroid carboxylic acids
WO2018050792A1 (en) Process for preparing esters of 12&#39;-apocarotenals as building blocks for carotenoids
CN110903264A (en) Method for preparing diazoxide
US7351862B2 (en) Alpha, omega-difunctional aldaramides
WO2018050795A1 (en) Process for preparing of carotenoid mono-esters
EP1084091B1 (en) Method for producing alkyl chloride, alkenyl chloride and alkinyl chloride
SU650499A3 (en) Method of obtaining amino esters or salts thereof
US2079541A (en) N-chlorosulphonylamides and method for their preparation
US3468900A (en) Process for preparing isoxazole compounds
WO2018050793A1 (en) Process for preparing phosphonium salt esters as building blocks for carotenoides
WO2018050794A1 (en) Process for preparing of carotenoid mono-esters
US3940439A (en) Acid chloride synthesis
JP3324191B2 (en) Method for producing substituted urea
Taub et al. Imido Esters. I. The Course of the Reaction Between Phthalic Anhydride and Caprolactam
WO1991003460A1 (en) New route of synthesis for tertiary alkyl esters
US3709934A (en) Method of making carboxylic acid anhydrides
US2580832A (en) Preparation of nitrilotrispropion-amide
IL35861A (en) Substituted benzimidic alkyl esters and their preparation
US2655528A (en) Sulfur trioxide compounds of pentaalkylguanidines
GB2137193A (en) Chlorosulphonic Acid Esters
JPS6228797B2 (en)
EP0612740B1 (en) Methods of producing pantothenic acid derivative and its starting materials for producing the same